9-104536707-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001001961.3(OR13C3):c.17A>T(p.Gln6Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000508 in 1,613,578 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001961.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR13C3 | NM_001001961.3 | c.17A>T | p.Gln6Leu | missense_variant | 1/1 | ENST00000641090.1 | NP_001001961.2 | |
LOC107987105 | XR_007061705.1 | n.635-6375A>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR13C3 | ENST00000641090.1 | c.17A>T | p.Gln6Leu | missense_variant | 1/1 | NM_001001961.3 | ENSP00000493076.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000878 AC: 22AN: 250706Hom.: 2 AF XY: 0.000125 AC XY: 17AN XY: 135520
GnomAD4 exome AF: 0.0000534 AC: 78AN: 1461270Hom.: 2 Cov.: 32 AF XY: 0.0000647 AC XY: 47AN XY: 726972
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 12, 2021 | The c.107A>T (p.Q36L) alteration is located in exon 1 (coding exon 1) of the OR13C3 gene. This alteration results from a A to T substitution at nucleotide position 107, causing the glutamine (Q) at amino acid position 36 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at